A critical breakthrough in cancer study is occurring with the use of mini-antibodies to restore dysfunctional p53. This crucial malignant protector protein is frequently inactivated in many forms of tumors, resulting https://bookmarkgenious.com/story22085740/mini-antibodies-revive-p53-the-potential-approach-for-malignant-management